142 related articles for article (PubMed ID: 37867180)
1. Kinetic assessment of iontophoretic delivery efficiency of niosomal tetracycline hydrochloride incorporated in electroconductive gel.
Duman G; Gucu E; Utku FS; Uner B; Macit M; Sarialtin S; Ozilgen M
Drug Deliv Transl Res; 2024 May; 14(5):1206-1217. PubMed ID: 37867180
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate.
Jain S; Chaudhari BH; Swarnakar NK
Drug Deliv Transl Res; 2011 Aug; 1(4):309-21. PubMed ID: 25788365
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of acyclovir cream and gel formulations for transdermal iontophoretic delivery.
Siddoju S; Sachdeva V; Friden PM; Banga AK
Ther Deliv; 2012 Mar; 3(3):327-38. PubMed ID: 22833993
[TBL] [Abstract][Full Text] [Related]
4. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
[No Abstract] [Full Text] [Related]
6. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
7. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
Al-Khalili M; Meidan VM; Michniak BB
AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
[TBL] [Abstract][Full Text] [Related]
10. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles.
Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J
J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277
[TBL] [Abstract][Full Text] [Related]
11. Iontophoretic Mediated Intraarticular Delivery of Deformable Liposomes of Diclofenac Sodium.
Vanaja K; S S; Murthy SN; Shivakumar HN
Curr Drug Deliv; 2021; 18(4):421-432. PubMed ID: 33059549
[TBL] [Abstract][Full Text] [Related]
12. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats.
Teaima M; Abdelmonem R; Adel YA; El-Nabarawi MA; El-Nawawy TM
Drug Des Devel Ther; 2021; 15():4603-4614. PubMed ID: 34785889
[TBL] [Abstract][Full Text] [Related]
13. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
14. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
15. Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation.
Rane BR; Chavan PY; Kate NS; Jain AS
Recent Adv Drug Deliv Formul; 2023; 17(4):300-313. PubMed ID: 37974444
[TBL] [Abstract][Full Text] [Related]
16. Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac).
Akbari J; Saeedi M; Morteza-Semnani K; Hashemi SMH; Babaei A; Eghbali M; Mohammadi M; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
J Drug Target; 2022 Jan; 30(1):108-117. PubMed ID: 34116599
[TBL] [Abstract][Full Text] [Related]
17. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
18. Formulation optimization,
Aldawsari MF; Khafagy ES; Moglad EH; Selim Abu Lila A
Saudi Pharm J; 2023 Sep; 31(9):101734. PubMed ID: 37649675
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
[TBL] [Abstract][Full Text] [Related]
20. Qbd-Based Approach to Optimize Niosomal Gel of Levosulpiride for Transdermal Drug Delivery.
Alnaim AS; Shah H; Nair AB; Mewada V; Patel S; Jacob S; Aldhubiab B; Morsy MA; Almuqbil RM; Shinu P; Shah J
Gels; 2023 Mar; 9(3):. PubMed ID: 36975662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
